New pill combo aims to delay chemo in advanced breast cancer
NCT ID NCT07647328
First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 3 times
Summary
This phase 3 trial is testing two oral drugs, camizestrant and ribociclib, as a first treatment for people with ER-positive, HER2-negative advanced breast cancer. The goal is to see if the combination can delay the need for next cancer therapy. About 150 participants will take the pills daily until their cancer progresses or side effects become too much.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- camizestrant and ribociclib (oral tablets)
- What this could lead to
- If successful, this combination could offer a new first-line treatment option that delays the need for further chemotherapy in advanced breast cancer.
- What could go wrong
- This is a single-arm, open-label study without a placebo group, so results may be less definitive. Side effects from the drug combination are possible, and the trial is still recruiting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ER-POSITIVE HER2-NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
NOT_YET_RECRUITINGDuarte, California, 91010, United States
-
Research Site
NOT_YET_RECRUITINGPalo Alto, California, 94304, United States
-
Research Site
RECRUITINGMarietta, Georgia, 30060, United States
-
Research Site
NOT_YET_RECRUITINGEvanston, Illinois, 60201, United States
-
Research Site
NOT_YET_RECRUITINGEdgewood, Kentucky, 41017, United States
-
Research Site
NOT_YET_RECRUITINGLouisville, Kentucky, 40202, United States
-
Research Site
NOT_YET_RECRUITINGReno, Nevada, 89502, United States
-
Research Site
NOT_YET_RECRUITINGSioux Falls, South Dakota, 57105, United States
-
Research Site
NOT_YET_RECRUITINGNashville, Tennessee, 37204, United States
-
Research Site
NOT_YET_RECRUITINGFort Worth, Texas, 76104, United States
-
Research Site
RECRUITINGKingwood, Texas, 77339, United States
-
Research Site
NOT_YET_RECRUITINGMidlothian, Virginia, 23114, United States
-
Research Site
NOT_YET_RECRUITINGAngers, 49933, France
-
Research Site
NOT_YET_RECRUITINGBayonne, 64109, France
-
Research Site
NOT_YET_RECRUITINGBobigny, 93000, France
-
Research Site
NOT_YET_RECRUITINGCaen, 14000, France
-
Research Site
NOT_YET_RECRUITINGChambray-lès-Tours, 37170, France
-
Research Site
NOT_YET_RECRUITINGGrenoble, 38043, France
-
Research Site
NOT_YET_RECRUITINGMontpellier, 34070, France
-
Research Site
NOT_YET_RECRUITINGNancy, 54100, France
-
Research Site
NOT_YET_RECRUITINGNîmes, 30029, France
-
Research Site
NOT_YET_RECRUITINGParis, 75014, France
-
Research Site
NOT_YET_RECRUITINGPierre-Bénite, 69310, France
-
Research Site
NOT_YET_RECRUITINGValenciennes, 59300, France
-
Research Site
NOT_YET_RECRUITINGVandœuvre-lès-Nancy, 54519, France
-
Research Site
NOT_YET_RECRUITINGVillejuif, 94805, France
-
Research Site
NOT_YET_RECRUITINGBerlin, 13125, Germany
-
Research Site
NOT_YET_RECRUITINGDüsseldorf, 40235, Germany
-
Research Site
NOT_YET_RECRUITINGErlangen, 91054, Germany
-
Research Site
NOT_YET_RECRUITINGFreiburg im Breisgau, 79110, Germany
-
Research Site
NOT_YET_RECRUITINGMönchengladbach, 41061, Germany
-
Research Site
NOT_YET_RECRUITINGMünchen, 81675, Germany
-
Research Site
NOT_YET_RECRUITINGPaderborn, 33098, Germany
-
Research Site
NOT_YET_RECRUITINGTrier, 54290, Germany
-
Research Site
NOT_YET_RECRUITINGVelbert, 42551, Germany
-
Research Site
NOT_YET_RECRUITINGAviano, 33081, Italy
-
Research Site
NOT_YET_RECRUITINGBergamo, 24127, Italy
-
Research Site
NOT_YET_RECRUITINGGenova, 16132, Italy
-
Research Site
NOT_YET_RECRUITINGMilan, 20127, Italy
-
Research Site
NOT_YET_RECRUITINGNaples, 80131, Italy
-
Research Site
NOT_YET_RECRUITINGGdansk, 80-952, Poland
-
Research Site
NOT_YET_RECRUITINGKonin, 62-500, Poland
-
Research Site
NOT_YET_RECRUITINGKrakow, 30-688, Poland
-
Research Site
NOT_YET_RECRUITINGLodz, 90-302, Poland
-
Research Site
NOT_YET_RECRUITINGLublin, 20-090, Poland
-
Research Site
NOT_YET_RECRUITINGPoznan, 61-485, Poland
-
Research Site
SUSPENDEDPrzemyśl, 37-700, Poland
-
Research Site
NOT_YET_RECRUITINGWroclaw, 53-413, Poland
-
Research Site
NOT_YET_RECRUITINGCheonan-si, 31151, South Korea
-
Research Site
SUSPENDEDDaegu, 42415, South Korea
-
Research Site
NOT_YET_RECRUITINGGoyang-si, 10408, South Korea
-
Research Site
NOT_YET_RECRUITINGHwasun-eup, 58128, South Korea
-
Research Site
NOT_YET_RECRUITINGIncheon, 405-760, South Korea
-
Research Site
NOT_YET_RECRUITINGSeongbuk-Gu, 02841, South Korea
-
Research Site
NOT_YET_RECRUITINGSeongnam-si, 13520, South Korea
-
Research Site
NOT_YET_RECRUITINGSeongnam-si, 13620, South Korea
-
Research Site
NOT_YET_RECRUITINGSeoul, 03080, South Korea
-
Research Site
NOT_YET_RECRUITINGSeoul, 06273, South Korea
-
Research Site
NOT_YET_RECRUITINGSeoul, 06351, South Korea
-
Research Site
NOT_YET_RECRUITINGSeoul, 06591, South Korea
-
Research Site
NOT_YET_RECRUITINGSeoul, 07985, South Korea
-
Research Site
NOT_YET_RECRUITINGSeoul, 3722, South Korea
-
Research Site
NOT_YET_RECRUITINGSongpa-gu, 05505, South Korea
-
Research Site
SUSPENDEDSuwon, 16499, South Korea
-
Research Site
NOT_YET_RECRUITINGBadajoz, 06080, Spain
-
Research Site
NOT_YET_RECRUITINGBadalona, 08916, Spain
-
Research Site
NOT_YET_RECRUITINGBarcelona, 08041, Spain
-
Research Site
NOT_YET_RECRUITINGBurgos, 9006, Spain
-
Research Site
NOT_YET_RECRUITINGDonostia / San Sebastian, 20014, Spain
-
Research Site
NOT_YET_RECRUITINGHuelva, 21005, Spain
-
Research Site
NOT_YET_RECRUITINGJaén, 23007, Spain
-
Research Site
NOT_YET_RECRUITINGLas Palmas de Gran Canaria, 35016, Spain
-
Research Site
NOT_YET_RECRUITINGMajadahonda, 28222, Spain
-
Research Site
NOT_YET_RECRUITINGMálaga, 29010, Spain
-
Research Site
NOT_YET_RECRUITINGMurcia, 30008, Spain
-
Research Site
NOT_YET_RECRUITINGOviedo, 33011, Spain
-
Research Site
NOT_YET_RECRUITINGPalma de Mallorca, 07198, Spain
-
Research Site
NOT_YET_RECRUITINGPontevedra, 36312, Spain
-
Research Site
NOT_YET_RECRUITINGPozuelo de Alarcón, 28223, Spain
-
Research Site
NOT_YET_RECRUITINGSantander, 39008, Spain
-
Research Site
NOT_YET_RECRUITINGToledo, 45007, Spain
-
Research Site
NOT_YET_RECRUITINGZaragoza, 50009, Spain
-
Research Site
NOT_YET_RECRUITINGBasel, 4031, Switzerland
-
Research Site
NOT_YET_RECRUITINGLiestal, CH-4410, Switzerland
-
Research Site
NOT_YET_RECRUITINGRennaz, 1847, Switzerland
-
Research Site
NOT_YET_RECRUITINGAbu Dhabi, 11241, United Arab Emirates
-
Research Site
NOT_YET_RECRUITINGAl Ain City, 00000, United Arab Emirates
-
Research Site
NOT_YET_RECRUITINGDubai, 505004, United Arab Emirates
-
Research Site
NOT_YET_RECRUITINGMohammed Bin Zayed City, 92510, United Arab Emirates
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart drug cross the Blood-Brain barrier to attack breast cancer metastases?
- Can a chemo pill mop up hidden breast cancer cells?
- New drug combo HRS8807 and SHR6390 targets tough breast cancer
- BREAST CANCER BREAKTHROUGH? new study lets patients choose chemo-free treatment
- Blood test catches cancer early: new drug aims to stop spread
- AI reads tumor slides to predict cancer return in early breast cancer